Abstract

Treating neuropathic pain with systemic opioids is associated with significant dose-limiting central nervous system (CNS) side effects, tolerance, and potential for addiction and drug abuse. Recent observation suggests a role for peripheral mu-opioid receptors (MORs) in neuropathic pain. To examine whether selective activation of peripheral MORs may attenuate neuropathic pain behavior in rats, a blinded, vehicle-controlled study was designed to test whether loperamide, a peripherally restricted MOR agonist, would attenuate the mechanical allodynia induced by ligation and transection of the L5 spinal nerve (SNL) in adult male rat.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call